chrX-147912049-CGCGGCGGCG-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_002024.6(FMR1):c.-108_-100del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000819 in 41,497 control chromosomes in the GnomAD database, including 1 homozygotes. There are 15 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00051 ( 0 hom., 4 hem., cov: 2)
Exomes 𝑓: 0.0025 ( 1 hom. 11 hem. )
Consequence
FMR1
NM_002024.6 5_prime_UTR
NM_002024.6 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.53
Genes affected
FMR1 (HGNC:3775): (fragile X messenger ribonucleoprotein 1) The protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant X-147912049-CGCGGCGGCG-C is Benign according to our data. Variant chrX-147912049-CGCGGCGGCG-C is described in ClinVar as [Benign]. Clinvar id is 1166634.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000512 (18/35174) while in subpopulation AMR AF= 0.000725 (2/2760). AF 95% confidence interval is 0.00032. There are 0 homozygotes in gnomad4. There are 4 alleles in male gnomad4 subpopulation. Median coverage is 2. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FMR1 | NM_002024.6 | c.-108_-100del | 5_prime_UTR_variant | 1/17 | ENST00000370475.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FMR1 | ENST00000370475.9 | c.-108_-100del | 5_prime_UTR_variant | 1/17 | 1 | NM_002024.6 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000512 AC: 18AN: 35174Hom.: 0 Cov.: 2 AF XY: 0.000690 AC XY: 4AN XY: 5800
GnomAD3 genomes
AF:
AC:
18
AN:
35174
Hom.:
Cov.:
2
AF XY:
AC XY:
4
AN XY:
5800
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00253 AC: 16AN: 6323Hom.: 1 AF XY: 0.00322 AC XY: 11AN XY: 3413
GnomAD4 exome
AF:
AC:
16
AN:
6323
Hom.:
AF XY:
AC XY:
11
AN XY:
3413
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000512 AC: 18AN: 35174Hom.: 0 Cov.: 2 AF XY: 0.000690 AC XY: 4AN XY: 5800
GnomAD4 genome
AF:
AC:
18
AN:
35174
Hom.:
Cov.:
2
AF XY:
AC XY:
4
AN XY:
5800
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 12, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at